Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Explore approachable ways to celebrate budgeting milestones and sustain motivation. From small rewards to public acknowledgments, find methods that resonate with you.
12,829 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Geopolitical tensions around Iran and Qatar could reshape global LNG supply. This article explains the potential mark...
Amazon stock fell about 3% on Friday as macro uncertainty and doubts about a $200B AI capital plan for 2026 weigh on ...
What can a millionaire interview teach you about building wealth? This article shares actionable routines, portfolio ...
Sabre, a travel-technology stalwart, is navigating a recovering travel market and shifting tech spend. This article b...
AMD has surged dramatically, but the AI data-center boom could still offer upside. This guide explores whether late a...
A quiet-upstart tech company just got upgraded by analysts after solid earnings. This under-the-radar growth stock ma...
WeRide (WRD) is navigating growth with ride-hailing, delivery, and autonomous tech. This Q1 2026 earnings-focused ana...
Pi Network reports rising KYC completion and robust Mainnet migration, as upgrades lay groundwork for smart contracts...
Rocket Lab stock is catching strong momentum this week. We break down the key drivers behind the rally, what it means...
Valr confirms a Kenya-focused expansion as regulators finalize digital asset rules and Kenya’s fintech scene accelera...
Investors woke up to news that rocket stock dropped today, sending shares of Rocket Lab into the spotlight. This arti...